Devil facial tumour disease
Devil facial tumour disease (DFTD) is an aggressive non-viral clonally transmissible cancer which affects Tasmanian devils, a marsupial native to Australia. DFTD was first described in 1996. In the subsequent decade the disease ravaged Tasmania's wild devils. Affected high-density populations suffered up to 100% mortality in 12–18 months. Between 1996 and 2015, the population dwindled by 95%.
There is often more than one primary tumour. Visible signs of DFTD begin with lumps of soft tissue around the mouth, which ulcerate. Tumours are locally aggressive, destroying the underlying bone of the jaw which interferes with feeding. Tumours may also cover the eyes. Devils usually die within six months from organ failure, secondary infection, or metabolic starvation. All affected devils eventually die.
The most plausible route of transmission is through biting, particularly when canine teeth come into direct contact with the diseased cells. Other modes of transmission may include the ingestion of infected carcasses and the sharing of food, both of which involve an allogeneic transfer of cells between unrelated individuals. The animals most likely to become infected are the fittest devil individuals.
DFTD tumours are large soft tissue masses which become centrally ulcerated. The tumours are composed of obules of nodules of round to spindle-shaped cells, often within a pseudocapsule. Tumours metastasize to regional lymph nodes involvement and systemically to the lungs, spleen, and heart.
Tasmanian devil cells have 14 chromosomes; the oldest-known strain of the tumour cells have thirteen chromosomes, nine of which are recognizable and four of which are mutated "marker" chromosomes. More recently evolved strains have an additional mutant marker chromosome, for a total of fourteen chromosomes. Researchers identified the cancer as a neuroendocrine tumour, and found identical chromosomal rearrangements in all the cancer cells. The karyotype anomalies of DFTD cells are similar to those of cancer cells from canine transmissible venereal tumour (CTVT), a cancer of dogs that is transmitted by physical contact. Among the mutations present in the tumour genome is trisomy in chromosome 5p, as well as several single base mutations, and short insertions and deletions, e.g., deletions in the chromosomes 1, 2 and 3. Some of the mutated or deleted genes in DFTD are RET, FANCD2, MAST3 and BTNL9-like gene.
In 2015, a second genetically distinct strain of DFTD was identified, which was tetraploid, not diploid like the main form of the cancer. The tetraploid form has been linked to lower mortality rates. The cell type origin of this strain of DFTD is unknown. Increased levels of tetraploidy have been shown to exist in the oldest strain of DFTD as of 2014, which correlates with the point at which devils became involved in a DFTD removal programme. Because ploidy slows the tumour growth rate, the DFTD removal programme has been suggested as a selective pressure favouring slower-growing tumours, and more generally that disease eradication programmes aimed at DFTD may encourage the evolution of DFTD. The existence of multiple strains may complicate attempts to develop a vaccine, and there are reports of concerns that the evolution of the cancer may allow it to spread to related species such as the quoll.
DFTD likely originated in the Schwann cells of a single devil. Schwann cells are found in the peripheral nervous system, and produce myelin and other proteins essential for the functions of nerve cells in the peripheral nervous system. Researchers sampled 25 tumours and found that the tumours were genetically identical. Using deep sequencing technology, the study authors then profiled the tumours' transcriptome, the set of genes that are active in tumours; the transcriptomes closely matched those of Schwann cells, revealing high activity in many of the genes coding for myelin basic protein production. Several specific markers were identified, including the MBP and PRX genes, which may enable veterinarians to more easily distinguish DFTD from other types of cancer, and may eventually help identify a genetic pathway that can be targeted to treat it.
Wild Tasmanian devil populations are being monitored to track the spread of the disease and to identify changes in disease prevalence. Field monitoring involves trapping devils within a defined area to check for the presence of the disease and determine the number of affected animals. The same area is visited repeatedly to characterise the spread of the disease over time. So far, it has been established that the short-term effects of the disease in an area can be severe. Long-term monitoring at replicated sites will be essential to assess whether these effects remain, or whether populations can recover. Field workers are also testing the effectiveness of disease suppression by trapping and removing diseased devils, with the expectation that removal of diseased devils from wild populations would decrease disease prevalence, allowing devils to survive beyond juvenile years and so to breed. One study reported that a system of culling prior to 2010 did not impede disease spread.
Picking a genetically diverse breeding stock, defined by the genome sequence, may help with conservation efforts. Two "insurance" populations of disease-free devils have been established at an urban facility in the Hobart suburb of Taroona and on Maria Island off the east coast of Tasmania. Captive breeding in mainland zoos is also a possibility.
Due to the decreased life expectancy of the devils with DFTD, affected individuals have begun breeding at younger ages in the wild, with reports that many only live to participate in one breeding cycle. Hence, Tasmanian devils appear to have changed breeding habits in response to the disease; females had previously begun to breed annually at age two, for about three more years, dying thereafter of a variety of causes. Populations are now characterised by onset of breeding at age one, dying of DFTD, on average, shortly thereafter. Social interactions have been seen to contribute to spread of DFTD in a local area.
The decline in devil numbers is also an ecological problem, since its presence in the Tasmanian forest ecosystem is believed to have prevented the establishment of the red fox, with the most recent known organism accidentally being introduced into Tasmania in 1998. Tasmanian devil young may now be more vulnerable to red fox predation, as pups are left alone for long periods of time.
In response to the impact of DFTD on Tasmanian devil populations, 47 devils have been shipped to mainland Australian wildlife parks to attempt to preserve the genetic diversity of the species. The largest of these efforts is the Devil Ark project in Barrington Tops, New South Wales; an initiative of the Australian Reptile Park. This project aims to create a set of one thousand genetically representative devils, and is now a major focus of the insurance policy. The Tasman peninsula is being considered as a possible "clean area" with the single narrow access point controlled by physical barriers. The Tasmanian Department of Primary Industries and Water is experimenting on culling infected animals with some signs of success.
A diagnostic blood test was developed in mid-2009 to screen for the disease. In early 2010, scientists found some Tasmanian devils, mostly in the north-west of Tasmania, that are genetically different enough for their bodies to recognise the cancer as foreign. They have only one Major Histocompatibility Complex, whereas the cancerous cells have both.
In 1996, a photographer from The Netherlands captured several images of devils with facial tumours near Mount William in Tasmania's northeast. Around the same time, farmers reported a decline in devil numbers. Menna Jones first encountered the disease in 1999 near Little Swanport, in 2001 capturing three devils with facial tumours on the Freycinet Peninsula.
The theory that cancer cells themselves could be an infective agent (the Allograft Theory) was first offered in 2006 by Pearse, Swift, and colleagues, who analyzed DFTD cells from devils in several locations, determining that all DFTD cells sampled were genetically identical to each other, and genetically distinct from their hosts and from all other individual Tasmanian devils whose genetics had been studied; this allowed them to conclude that the cancer originated from a single individual and spread from it, rather than arising repeatedly, and independently. Twenty one different subtypes have been identified by analyzing the mitochondrial and nuclear genomes of 104 tumours from different Tasmanian devils. Researchers have also witnessed a previously-uninfected devil develop tumours from lesions caused by an infected devil's bites, supporting the contention that the disease is spread by allograft, with transmission via biting, scratching, and aggressive sexual activity between individuals. During biting, infection can spread from the bitten devil to the biter.
Initially, it was suspected that devils had low genetic diversity, so that their immune system did not recognise the tumour cells as foreign. However, it was later demonstrated that devils are sufficiently genetically diverse to mount a strong immune response to foreign tissue.
Since June 2005, three females have been found that are partially resistant to DFTD.
The devil population on the peninsula decreased dramatically. In March 2003 Nick Mooney wrote a memo to be circulated within the Parks and Wildlife Services calling for more funding to study the disease, but the call for funding was edited out before the memo was presented to Bryan Green, then Tasmania's Minister for Primary Industries, Water and Environment. In April 2003, a working group was formed by the Tasmanian Government to respond to the disease. In September 2003, Nick Mooney went to the Tasmanian daily newspaper The Mercury, informing the general public of the disease and proposing a quarantine of healthy Tasmanian devils. At the time, it was thought that a retrovirus was a possible cause. David Chadwick of the state Animal Health Laboratory said that the laboratory did not have the resources needed to research the possibility of a retrovirus. The Tasmanian Conservation Trust criticised the Tasmanian government for providing insufficient funds for research and suggested that DFTD could be zoonotic, posing a threat to livestock and humans. On 14 October 2003, a workshop was held in Launceston. In 2004, Kathryn Medlock found three oddly shaped devil skulls in European museums and found a description of a devil in London Zoo dying, which showed a similarity to DFTD.
Calicivirus, 1080 poison, agricultural chemicals, and habitat fragmentation combined with a retrovirus were other proposed causes. Environmental toxins had also been suspected. In March 2006 a devil escaped from a park into an area infected with DFTD. She was recaptured with bite marks on her face, and returned to live with the other devils in the park. She wounded a male and by October both devils had DFTD, which was subsequently spread to two others (an incident that in retrospect would be understood in the context of the allograft theory of transmission).
In 2006, DFTD was classed a List B notifiable disease under the Government of Tasmania's Animal Health Act 1995. The strategy of developing an insurance population in captivity was developed. It was reassessed in 2008. A 2007 investigation into the immune system of the devils found that when combatting other pathogens, the response from the immune system was normal, leading to suspicion that the devils were not capable of detecting the cancerous cells as "non-self". In 2007, it was predicted that populations could become locally extinct within 10–15 years of DFTD occurring, and predicted that the disease would spread across the entire range of the Tasmanian devils causing the devils to become extinct within 25–35 years.
In 2016, devils are at the verge of extinction as the localized populations were shown to be declined by 90 percent and an overall species decline of more than 80 percent in less than 20 years, with some models predicting extinction. Despite this, devil populations persist in disease-stricken areas. The devils have, in a way, fought back the extinction by developing the gene that is immune to face tumors. The genes have already existed in the Tasmanian devil as part of their immune system. They increased in frequency due to natural selection. That is, the individuals with particular forms of these genes (alleles) survived and reproduced disproportionately to those that lacked the specific variants when disease was present.
A devil population in the far southwest of Tasmania has been reported to be free of DFTD.
Society and culture
In 2008, a devil—given the name Cedric by those who treated and worked with him—was thought to have a natural immunity to the disease, but developed two facial tumours in late 2008. The tumours were removed, and officials thought Cedric was recovering well; but in September 2010, the cancer was discovered to have spread to the lungs, leading to his euthanasia.
Vaccination with irradiated cancer cells has not proven successful.
In 2013, a study using mice as a model for Tasmanian devils suggested that a DFTD vaccine could be beneficial. In 2015, a study which mixed dead DFTD cells with an inflammatory substance stimulated an immune response in five out of six devils injected with the mixture, engendering for a vaccine against DFTD. Field testing of the potential vaccine is being undertaken as a collaborative project between the Menzies Institute for Medical Research and the Save the Tasmanian Devil Program under the Wild Devil Recovery program, and aims to test the immunisation protocol as a tool in ensuring the devil's long term survival in the wild.
In March 2017, scientists at the University of Tasmania presented an apparent first report of having successfully treated Tasmanian devils with the disease, by injecting live cancer cells into the infected devils to stimulate their immune system to recognise and fight the disease.
- "Identification of candidate genes for devil facial tumour disease tumourigenesis | Scientific Reports". Retrieved 2018-08-21.
- Bender, Hannah S. (2010). "23. Devil facial tumour disease (DFTD): Using genetics and genomics to investigate infectious disease in an endangered marsupial". In Waters, Paul D.; Deakin, Janine E.; Marshall Graves, Jennifer A. Marsupial genetics and genomics. Dordrecht: Springer. pp. 499–516. ISBN 9789048190232.
- "Department of Primary Industries, Parks, Water and Environment". dpiwe.tas.gov.au. Retrieved 23 April 2017.
- Wahlquist, Calla (30 December 2015). "Tasmanian devils can catch second strain of facial cancer, say researchers". The Guardian. Retrieved 2018-01-27.
- Loh, R; Bergfeld, J; Hayes, D; O'hara, A; Pyecroft, S; Raidal, S; Sharpe, R (November 2006). "The pathology of devil facial tumor disease (DFTD) in Tasmanian Devils (Sarcophilus harrisii)". Veterinary Pathology. 43 (6): 890–5. doi:10.1354/vp.43-6-890. PMID 17099145.
- Vogelnest, Larry; Woods, Rupert, eds. (2008). "9.1.3 Tasmanian devil facial tumour disease (DFTD)". Medicine of Australian Mammals. Csiro Publishing. ISBN 9780643099289.
- O'Neill, Iain D. (2010). "Tasmanian devil facial tumor disease: Insights into reduced tumor surveillance from an unusual malignancy". International Journal of Cancer. 127 (7): 1637–42. doi:10.1002/ijc.25374. PMID 20473867.
- McCallum, Hamish (November 2008). "Tasmanian devil facial tumour disease: lessons for conservation biology". Trends in Ecology & Evolution. 23 (11): 631–637. doi:10.1016/j.tree.2008.07.001.
- Deakin, Janine E.; Belov, Katherine (2012). "A comparative genomics approach to understanding transmissible cancer in Tasmanian devils". Annual Review of Genomics and Human Genetics. 13 (1): 207–222. doi:10.1146/annurev-genom-090711-163852. PMID 22657390.
- Grueber, Catherine E.; Peel, Emma; Gooley, Rebecca; Belov, Katherine (September 2015). "Genomic insights into a contagious cancer in Tasmanian devils". Trends in Genetics. 31 (9): 528–535. doi:10.1016/j.tig.2015.05.001.
- Lachish, Shelly; McCallum, Hamish; Jones, Menna (March 2009). "Demography, disease and the devil: life-history changes in a disease-affected population of Tasmanian devils (Sarcophilus harrisii)". Journal of Animal Ecology. 78 (2): 427–436. doi:10.1111/j.1365-2656.2008.01494.x. JSTOR 27696382.
- Hawkins CE, McCallum H, Mooney N, Jones M, Holdsworth M. (2009). Sarcophilus harrisii. In: IUCN red list of threatened species. Version 2009.1.[full citation needed]
- Janeway CA, Travers P, Walport M, Shlomchik M. (2001). Immunobiology. Garland Publishing, New York, NY.[page needed]
- McCallum, Hamish; Jones, Menna; Hawkins, Clare; Hamede, Rodrigo; Lachish, Shelly; Sinn, David L.; Beeton, Nick; Lazenby, Billie (December 2009). "Transmission dynamics of Tasmanian devil facial tumor disease may lead to disease-induced extinction". Ecology. 90 (12): 3379–3392. doi:10.1890/08-1763.1. PMID 20120807.
- Wells, Konstans; Hamede, Rodrigo K.; Kerlin, Douglas H.; Storfer, Andrew; Hohenlohe, Paul A.; Jones, Menna E.; McCallum, Hamish I.; Ezenwa, Vanessa (June 2017). "Infection of the fittest: devil facial tumour disease has greatest effect on individuals with highest reproductive output". Ecology Letters. 20 (6): 770–778. doi:10.1111/ele.12776. PMID 28489304.
- "Bites spread fatal 'devil' cancer". BBC News. 2006-02-02. Retrieved 2018-01-27.
- Deakin, J.E.; et al. (2012). "Genomic restructuring in the Tasmanian devil facial tumour: Chromosome painting and gene mapping provide clues to evolution of transmissible tumour". PLOS Genetics. 8 (2): e1002483. doi:10.1371/journal.pgen.1002483.
- Pearse, A.-M.; et al. (2012). "Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor". Cancer Genetics. 205 (3): 101–112. doi:10.1016/j.cancergen.2011.12.001.
- Bostanci, A. (2005). "A Devil of a Disease". Science. 307 (5712): 1035. doi:10.1126/science.307.5712.1035. PMID 15718445.
- Murchison, Elizabeth P.; Schulz-Trieglaff, Ole B.; Ning, Zemin; Alexandrov, Ludmil B.; Bauer, Markus J.; Fu, Beiyuan; Hims, Matthew; Ding, Zhihao; Ivakhno, Sergii; Stewart, Caitlin; et al. (17 February 2012). "Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer". Cell. 148 (4): 780–791. doi:10.1016/j.cell.2011.11.065. PMC . PMID 22341448.
- Flies, Andrew S.; Lyons, A. Bruce; Corcoran, Lynn M.; Papenfuss, Anthony T.; Murphy, James M.; Knowles, Graeme W.; Woods, Gregory M.; Hayball, John D. (9 December 2016). "PD-L1 is not constitutively expressed on Tasmanian devil facial tumor cells but is strongly upregulated in response to IFN-γ and can be expressed in the tumor microenvironment". Frontiers in Immunology. 7. doi:10.3389/fimmu.2016.00581. PMC . PMID 28018348.
- "Tasmanian Devil tumor type linked with survival rates". 2 September 2015.
- Siddle, H. V. (April 2017). "Cancer as a contagious disease". HLA. 89 (4): 209–214. doi:10.1111/tan.12980.
- Ujvari, Beata; Pearse, Anne-Maree; Swift, Kate; Hodson, Pamela; Hua, Bobby; Pyecroft, Stephen; Taylor, Robyn; Hamede, Rodrigo; Jones, Menna; Belov, Katherine; Madsen, Thomas (February 2014). "Anthropogenic selection enhances cancer evolution in Tasmanian devil tumours". Evolutionary Applications. 7 (2): 260–265. doi:10.1111/eva.12117.
- "New Tas devil tumour strands 'harder to vaccinate' – ABC News (Australian Broadcasting Corporation)". ABC.net.au. 2008-07-25. Retrieved 2010-01-03.
- Murchison, E. P.; Tovar, C.; Hsu, A.; Bender, H. S.; Kheradpour, P.; Rebbeck, C. A.; Obendorf, D.; Conlan, C.; Bahlo, M.; Blizzard, C. A.; et al. (2009). "The Tasmanian Devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer". Science. 327 (5961): 84–87. doi:10.1126/science.1180616. PMC . PMID 20044575.
- Kinver, Mark (1 January 2010). "Tasmanian devil facial cancer origins 'identified'". BBC.
- Walsh, Bryan (1 January 2010). "Decoding the Tasmanian Devil's Deadly Cancer". Time.
- "Department of Primary Industries, Parks, Water and Environment" (PDF). Dpiwe.tas.gov.au. 2014-03-27. Retrieved 2017-04-26.
- Lachish, Shelly; McCallum, Hamish; Mann, Dydee; Pukk, Christy E.; Jones, Menna E. (2010). "Evaluation of Selective Culling of Infected Individuals to Control Tasmanian Devil Facial Tumor Disease". Conservation Biology. 24 (3): 841–851. doi:10.1111/j.1523-1739.2009.01429.x. PMID 20088958.
- Miller, Webb; et al. (27 June 2011). "Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil)". Proceedings of the National Academy of Sciences. 108 (30): 12348–12353. doi:10.1073/pnas.1102838108. PMC .
- Zimmer, Carl (22 January 2013). "Raising Devils in Seclusion". New York Times.
- Owen 2005, p. 6.
- "Archived copy" (PDF). Archived from the original (PDF) on 2011-03-04. Retrieved 2010-11-14.
- Department of the Environment (2017). Sarcophilus harrisii in Species Profile and Threats Database, Department of the Environment, Canberra.
- Bostanci A (2005). "A Devil of a Disease". Science. 307 (5712): 1035. doi:10.1126/science.307.5712.1035. PMID 15718445.
- "DPIW – Fox Impact on Wildlife". Dpiw.tas.gov.au. 2010-05-25. Retrieved 2010-09-11.
- "The Tasmanian Devil Needs a Saviour". Devil Ark. Retrieved 2011-04-19.
- Scientific American, March 2007.
- Quammen, David. Contagious cancer: the evolution of a killer, Harper's Magazine, April 2008.
- "A pre-tumour diagnostic test for DFTD". Tassiedevil.com.au. 2009-06-15. Retrieved 2010-09-11.
- Denholm, Matthew (2010-03-10). "Genetic study raises hopes for Tasmanian devils hit by facial tumour disease". The Australian. Retrieved 2010-09-11.
- Czarny, N.A.; Rodger, J.C. (2010). "Vitrification as a method for genome resource banking oocytes from the endangered Tasmanian devil (Sarcophilus harrisii)☆". Cryobiology. 60 (3): 322–5. doi:10.1016/j.cryobiol.2010.02.007. PMID 20219455.
- Epstein, Brendan (2016-08-30). "Rapid evolutionary response to a transmissible cancer in Tasmanian devils". Nature Communications. 7: 12684. doi:10.1038/ncomms12684. PMC . PMID 27575253.
- "Devil Tumors". radiolab.org. Retrieved 23 April 2017.
- Owen 2005, p. 170f.
- "Tasmanian devils threatened by facial tumour disease". Science Show. Australian Broadcasting Corporation. 2007-04-21. Retrieved 2010-10-08.
- Pearse, A-M., Swift, K. (2006). "Allograft theory: Transmission of devil facial-tumour disease". Nature. 439 (7076): 549. doi:10.1038/439549a. PMID 16452970.
- Pearse, A.-M.; Swift, K. (2006-02-02). "Allograft theory: transmission of devil facial-tumour disease". Nature. 439 (7076): 549. doi:10.1038/439549a. ISSN 1476-4687. PMID 16452970.
- "Tasmanian devils felled by rare cancer". New Scientist. 1 February 2006. Retrieved 2018-01-27.(subscription required)
- Obendorf, D. L. & MacGlashan, N.D. (2008). "Research Priorities in the Tasmanian Devil Facial Tumor Debate". European Journal of Oncology. 13: 229–238.
- Hamede, Rodrigo K.; McCallum, Hamish; Jones, Menna; Boots, Mike (January 2013). "Biting injuries and transmission of Tasmanian devil facial tumour disease". Journal of Animal Ecology. 82 (1): 182–190. doi:10.1111/j.1365-2656.2012.02025.x.
- Dennis, Carina (2006-02-02). "Endangered species: Time to raise the devil". Nature. 439 (7076): 530. doi:10.1038/439530a. PMID 16452951.
- Owen 2005, p. 177.
- "Tasmanian Devils - Spread of Disease". Parliamentary Debates (Hansard). Tasmania: House of Assembly. 29 October 2003. Part 2: pp. 31–104. Archived from the original on October 9, 2010. (part 2) 3:30 pm (Jeremy Rockliff, Shadow Minister for Primary Industries, Water and Environment; Nick McKim, Tasmanian Greens; Bryan Green, Minister for Primary Industries, Water and Environment).
- Bryan Green, Minister for Primary Industries, Water and Environment (20 August 2003). "Tasmanian Devils and the Spread of Cancer". Parliamentary Debates (Hansard). Tasmania: House of Assembly. Part 1: pp. 1–29. Archived from the original on October 9, 2010. (10:58 am) (part 1)
- Wood, Danielle (1 September 2003). "Tassie devil under threat". The Mercury. Hobart Town, Tasmania. p. 1.
- "Wildlife specialists concerned about Tassie Devil disease". Australian Broadcasting Corporation. 2003-10-14. Retrieved 2010-10-08.
- "Devil Disease". Stateline Tasmania. Australian Broadcasting Corporation. 2004-09-10. Retrieved 2010-10-08.
- Owen 2005, p. 178.
- Owen 2005, p. 184f.
- "Research priorities in the Tasmanian devil facial tumour debate" (PDF). European Journal of Oncology. 13: 229–238. 2008.
- "Frequently Asked Questions About Devil Facial Tumour Disease" (PDF).
- Conservation Breeding Specialist Group (2008). "Tasmanian Devil PHVA Final Report" (PDF). Apple Valley, Minnesota: IUCN/SSC Conservation Breeding Specialist Group. Retrieved 2 October 2010.
- Woods, Gregory M.; Kreiss, Alexandre; Belov, Katherine; Siddle, Hannah V.; Obendorf, David L.; Muller, H. Konrad (2007). "The Immune Response of the Tasmanian Devil (Sarcophilus harrisii) and Devil Facial Tumour Disease". EcoHealth. 4 (3): 338–345. doi:10.1007/s10393-007-0117-1.
- McCallum, Hamish; Tompkins, Daniel M.; Jones, Menna; Lachish, Shelly; Marvanek, Steve; Lazenby, Billie; Hocking, Greg; Wiersma, Jason; Hawkins, Clare E. (2007). "Distribution and Impacts of Tasmanian Devil Facial Tumor Disease". EcoHealth. 4 (3): 318–325. doi:10.1007/s10393-007-0118-0.
- "Tasmanian devils evolve resistance to facial cancers". ResearchGate. Retrieved 2016-08-30.
- Epstein, Brendan; Jones, Menna; Hamede, Rodrigo; Hendricks, Sarah; McCallum, Hamish; Murchison, Elizabeth P.; Schönfeld, Barbara; Wiench, Cody; Hohenlohe, Paul (2016-08-30). "Rapid evolutionary response to a transmissible cancer in Tasmanian devils". Nature Communications. 7: 12684. doi:10.1038/ncomms12684. ISSN 2041-1723. PMC . PMID 27575253.
- "Healthy Tasmanian devils found in mission to save species from extinction". ABC News. 28 April 2018. Retrieved 30 April 2018.
- "BBC NEWS - World - Asia-Pacific - Fence hope for Tasmanian Devils". bbc.co.uk. Retrieved 23 April 2017.
- "Cancer-related death for Cedric the devil – ABC News (Australian Broadcasting Corporation)". ABC.net.au. 2010-09-01. Retrieved 2010-09-11.
- Borrell, Brendan (31 December 2009). "Hopes of a tumour test for Tasmanian devils". doi:10.1038/news.2009.1169. Retrieved 23 April 2017.
- Pinfold, Terry L.; Brown, Gabriella K.; Bettiol, Silvana S.; Woods, Gregory M. (27 May 2014). "Mouse model of devil facial tumour disease establishes that an effective immune response can be generated against the cancer cells". Frontiers in Immunology. 5. doi:10.3389/fimmu.2014.00251.
- "Tasmanian devil facial tumour vaccine a step closer, researchers say". ABC News.
- Kreiss, A.; Brown, G.K.; Tovar, C.; Lyons, A.B.; Woods, G.M. (February 2015). "Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations". Vaccine. doi:10.1016/j.vaccine.2015.01.039.
- "Save the Tasmanian Devil Program moves closer to immunised devil trial". 25 February 2015. Retrieved 14 April 2015.
- Tovar, Cesar; Pye, Ruth J.; Kreiss, Alexandre; Cheng, Yuanyuan; Brown, Gabriella K.; Darby, Jocelyn; Malley, Roslyn C.; Siddle, Hannah V. T.; Skjødt, Karsten; Kaufman, Jim; Silva, Anabel; Morelli, Adriana Baz; Papenfuss, Anthony T.; Corcoran, Lynn M.; Murphy, James M.; Pearse, Martin J.; Belov, Katherine; Lyons, A. Bruce; Woods, Gregory M. (9 March 2017). "Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils". 7. doi:10.1038/srep43827. PMC . PMID 28276463.
- O'Connor, Ted (9 March 2017). "Live cancer cell injection helps beat devil facial tumour disease". ABC News. Retrieved 2018-01-27.